Showing results (151-160 of 170) with videos related to
Sort By:
Pageof 17
Journal of Neurology, Neurosurgery, and Psychiatry|October 16, 1999
Interferon-beta-1a in relapsing-remitting multiple sclerosis: effect on hypointense lesion volume on T1 weighted imagesC Gasperini, C Pozzilli, S Bastianello, et al.Arthritis and Rheumatism|July 21, 2000
A novel missense mutation (C30S) in the gene encoding tumor necrosis factor receptor 1 linked to autosomal-dominant recurrent fever with localized myositis in a French familyC Dodé, T Papo, C Fieschi, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 21, 2004
Prognostic significance of admission levels of troponin I in patients with acute ischaemic strokeE Di Angelantonio, M Fiorelli, D Toni, et al.European Neurology|January 1, 1983
Italian study of cerebral reversible ischemic attacks. II. The hematocrit and hemoglobin distribution and its relationship between clinical pattern and angiographic abnormalitiesM Nardini, G Rossi, A Martini, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 10, 1998
Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1aG Antonelli, F Bagnato, C Pozzilli, et al.Journal of Neurovirology|June 29, 2000
MRI of spinal cord in MSS Bastianello, A Paolillo, E Giugni, et al.Acta Neurologica Scandinavica|April 1, 1997
The influence of clinical relapses and steroid therapy on the development of Gd-enhancing lesions: a longitudinal MRI study in relapsing-remitting multiple sclerosis patientsC Gasperini, C Pozzilli, S Bastianello, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 1, 1996
Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosisC Pozzilli, S Bastianello, T Koudriavtseva, et al.European Annals of Otorhinolaryngology, Head and Neck Diseases|March 25, 2014
French ENT Society (SFORL) guidelines for the management of immunodeficient patients with head and neck cancer of cutaneous originC Bejar, N Basset-Seguin, F Faure, et al.Stroke|October 7, 2000
Morphological and functional characteristics of patent foramen ovale and their embolic implicationsS De Castro, D Cartoni, M Fiorelli, et al.Pageof 17